Log in
Register|
ABE1580 ☆ India, 2012-06-19 11:59 (4322 d 22:13 ago) Posting: # 8788 Views: 4,672 |
|
|
We are about to conduct a replicate BE study for one of the HVD. Is there any advantage of replicate design over cross-over design to identify outliers? |
|
ABE1580 ☆ India, 2012-06-23 09:49 (4319 d 00:23 ago) @ ABE1580 Posting: # 8831 Views: 3,781 |
|
|
Helmut ★★★   Vienna, Austria, 2012-06-23 13:44 (4318 d 20:28 ago) @ ABE1580 Posting: # 8832 Views: 3,783 |
|
|
❝ Dear HS, Do you think that I am the only qualified user here and should answer your succinct posts? ❝ Any opinions? Yes, I do have some. For details see the Policy, second paragraph. Sends me into hibernation. As an appetizer read: Schall R, Endrényi L, Ring A. Residuals and Outliers in Replicate Design Crossover Studies. J Biopharmaceut Stat. 2010;20:835–49. doi:10.1080/10543401003618876 Then come back.— Dif-tor heh smusma 🖖🏼 Довге життя Україна! ![[image]](https://static.bebac.at/pics/Blue_and_yellow_ribbon_UA.png) Helmut Schütz ![[image]](https://static.bebac.at/img/CC by.png) The quality of responses received is directly proportional to the quality of the question asked. 🚮 Science Quotes |
Ing. Helmut Schütz